Stocksigma LogoStocksigma Logo

Asston Pharmaceuticals Reports H1 FY27 Results and Preferential Allotment

For the half-year ended 30th Sep'26, Asston Pharmaceuticals reported revenue from operations of ₹1,526.58 lakhs, down 0.98% YoY from ₹1,541.59 lakhs in the

Asston Pharmaceuticals Reports H1 FY27 Results and Preferential Allotment

Asston Pharmaceuticals Ltd · Outcome · 12 Nov 2026, 11:30 pm

Asston Pharmaceuticals Reports H1 FY27 Results and Preferential Allotment For the half-year ended 30th Sep'26, Asston Pharmaceuticals reported revenue from operations of ₹1,526.58 lakhs, down 0.98% YoY from ₹1,541.59 lakhs in the half-year ended 30th Sep'25. Net profit contracted 3.20% YoY to ₹327.37 lakhs versus ₹338.21 lakhs. PBT stood at ₹437.33 lakhs compared to ₹337.32 lakhs a year earlier. Basic EPS declined to ₹3.70 from ₹9.35. During the period, the company raised ₹2,771.60 lakhs via a preferential allotment of 24.10 lakh equity shares at ₹115 per share on 5th Sep'26.

Original exchange filing (PDF)

More announcements from Asston Pharmaceuticals Ltd

All Asston Pharmaceuticals Ltd announcements